Importantly, tumor‐bearing mice receiving combination treatment of RGD4C/AAVP‐Grp78‐HSVtk/GCV with TMZ showed the highest survival benefit as compared to TMZ or RGD4C/AAVP‐Grp78‐HSVtk/GCV alone. The gene discussed is HSPA5; the disease is neoplasm.